VK-0214
- Generic Name
- VK-0214
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H25O5P
- CAS Number
- 852949-30-5
- Unique Ingredient Identifier
- 6FGG71NJ3Y
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Viking Therapeutics, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT04973657
- Locations
- 🇫🇷
Viking Clinical Site 214, Bordeaux, France
🇺🇸Viking Clinical Site 205, Seattle, Washington, United States
🇮🇹Viking Clinical Site 210, Milano, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath